These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21406558)

  • 1. Activation of miR-31 function in already-established metastases elicits metastatic regression.
    Valastyan S; Chang A; Benaich N; Reinhardt F; Weinberg RA
    Genes Dev; 2011 Mar; 25(6):646-59. PubMed ID: 21406558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis.
    Valastyan S; Chang A; Benaich N; Reinhardt F; Weinberg RA
    Cancer Res; 2010 Jun; 70(12):5147-54. PubMed ID: 20530680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β upregulates miR-181a expression to promote breast cancer metastasis.
    Taylor MA; Sossey-Alaoui K; Thompson CL; Danielpour D; Schiemann WP
    J Clin Invest; 2013 Jan; 123(1):150-63. PubMed ID: 23241956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism.
    Rahmani M; Aust MM; Attkisson E; Williams DC; Ferreira-Gonzalez A; Grant S
    Cancer Res; 2013 Feb; 73(4):1340-51. PubMed ID: 23243017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant suppression of three target genes can explain the impact of a microRNA on metastasis.
    Valastyan S; Benaich N; Chang A; Reinhardt F; Weinberg RA
    Genes Dev; 2009 Nov; 23(22):2592-7. PubMed ID: 19875476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis.
    Valastyan S; Reinhardt F; Benaich N; Calogrias D; Szász AM; Wang ZC; Brock JE; Richardson AL; Weinberg RA
    Cell; 2009 Jun; 137(6):1032-46. PubMed ID: 19524507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.
    Lei R; Tang J; Zhuang X; Deng R; Li G; Yu J; Liang Y; Xiao J; Wang HY; Yang Q; Hu G
    Oncogene; 2014 Mar; 33(10):1287-96. PubMed ID: 23474751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiopoietin-2, an angiogenic regulator, promotes initial growth and survival of breast cancer metastases to the lung through the integrin-linked kinase (ILK)-AKT-B cell lymphoma 2 (Bcl-2) pathway.
    Imanishi Y; Hu B; Xiao G; Yao X; Cheng SY
    J Biol Chem; 2011 Aug; 286(33):29249-29260. PubMed ID: 21680733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway.
    Sheth S; Jajoo S; Kaur T; Mukherjea D; Sheehan K; Rybak LP; Ramkumar V
    PLoS One; 2012; 7(12):e51655. PubMed ID: 23272133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.
    Song HM; Luo Y; Li DF; Wei CK; Hua KY; Song JL; Xu H; Maskey N; Fang L
    Int J Clin Exp Pathol; 2015; 8(9):9889-900. PubMed ID: 26617698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells.
    Png KJ; Halberg N; Yoshida M; Tavazoie SF
    Nature; 2011 Dec; 481(7380):190-4. PubMed ID: 22170610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-17-92a upregulation by estrogen leads to Bim targeting and inhibition of osteoblast apoptosis.
    Guo L; Xu J; Qi J; Zhang L; Wang J; Liang J; Qian N; Zhou H; Wei L; Deng L
    J Cell Sci; 2013 Feb; 126(Pt 4):978-88. PubMed ID: 23264746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma.
    Teshima K; Nara M; Watanabe A; Ito M; Ikeda S; Hatano Y; Oshima K; Seto M; Sawada K; Tagawa H
    Oncogene; 2014 Apr; 33(17):2191-203. PubMed ID: 23686310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations.
    Thomsen KG; Terp MG; Lund RR; Søkilde R; Elias D; Bak M; Litman T; Beck HC; Lyng MB; Ditzel HJ
    Oncotarget; 2015 Oct; 6(30):29224-39. PubMed ID: 26317550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
    Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
    J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects.
    Yang J; Jiang H; Wang C; Yang B; Zhao L; Hu D; Qiu G; Dong X; Xiao B
    Biomed Pharmacother; 2015 May; 72():125-34. PubMed ID: 26054686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.
    Ma L; Young J; Prabhala H; Pan E; Mestdagh P; Muth D; Teruya-Feldstein J; Reinhardt F; Onder TT; Valastyan S; Westermann F; Speleman F; Vandesompele J; Weinberg RA
    Nat Cell Biol; 2010 Mar; 12(3):247-56. PubMed ID: 20173740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-150 promotes cervical cancer cell growth and survival by targeting FOXO4.
    Li J; Hu L; Tian C; Lu F; Wu J; Liu L
    BMC Mol Biol; 2015 Dec; 16():24. PubMed ID: 26715362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid-mediated repression of the oncogenic microRNA cluster miR-17~92 contributes to the induction of Bim and initiation of apoptosis.
    Molitoris JK; McColl KS; Distelhorst CW
    Mol Endocrinol; 2011 Mar; 25(3):409-20. PubMed ID: 21239610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis.
    Berlanga P; Muñoz L; Piqueras M; Sirerol JA; Sánchez-Izquierdo MD; Hervás D; Hernández M; Llavador M; Machado I; Llombart-Bosch A; Cañete A; Castel V; Font de Mora J
    Mol Oncol; 2016 Aug; 10(7):1043-53. PubMed ID: 27155790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.